by Agathe Masson | Dec 9, 2024 | Access to Care, NCD Policy, News
Access to essential treatments is a cornerstone of effective healthcare systems. Both brand-name medicines and generics play vital roles in ensuring that patients receive the care they need. While brand-name medicines are often associated with innovation and...
by Agathe Masson | Nov 19, 2024 | Healthcare Systems, NCD Policy, News
“Localisation.” It’s a term we’ve heard frequently in recent years, but not without its critics—and perhaps rightly so. Many argue that “localisation” doesn’t fully capture the essence of legitimising communities to lead their own health solutions, often implying a...
by Agathe Masson | Sep 9, 2024 | NCD Financing, NCD Policy, News
Over the past two decades, noncommunicable diseases (NCDs) and mental health have evolved from niche concerns in global health to central pillars of the sustainable development agenda. Since the 2011 High-level Meeting on the Prevention and Control of NCDs,...
by Callie Weber | Jan 8, 2024 | Access to Care, NCD Policy, News
Counterfeit and substandard medicine trafficking is one of the world’s fastest-growing and highest-value criminal enterprises. Analysts estimate the global counterfeit market to be worth between US$200 and $432 billion. Since the issue first came to light in a 2003...
